Intracellular and plasma efavirenz concentrations in HIV-infected patients switching from successful protease inhibitor-based highly active antiretroviral therapy (HAART) to efavirenz-based HAART (SUSTIPHAR Study).

Source:http://linkedlifedata.com/resource/pubmed/id/16921181

Download in:

View as

General Info

PMID
16921181